Skip to main content

Table 4 Sensibility, specificity, positive predictive value and negative predictive value of risk factors questions for hepatitis B virus positivity, hepatitis C virus positivity and hepatitis B or hepatitis C positivity

From: Prevalence of hepatitis B and C and sensibility of a selective screening questionnaire in patients receiving chemotherapy for solid tumors

  HBV HCV HBV or HCV
  Sea
[95 % CI]
Spb
[95 % CI]
PPVc
[95 % CI]
NPVd
[95 % CI]
Sea
[95 % CI]
Spb
[95 % CI]
PPVc
[95 % CI]
NPVd
[95 % CI]
Sea
[95 % CI]
Spb
[95 % CI]
PPVc
[95 % CI]
NPVd
[95 % CI]
Major surgery/bleeding prior 1992 15.2 84.9 8.8 91.3 0.0 84.6 0.0 98.4 13.9 84.7 8.8 90.3
[2.9-27.4] [81.1-88.7] [1.4-16.1] [88.2-94.3] [81.0-88.3]   [97.1-99.8] [2.6-25.2] [80.9-88.5] [1.4-16.1] [87.0-93.5]
Acupuncture, tattoo or piercing without disposable devices 12.5 85.2 7.3 91.3 40.0 85.7 3.6 99.1 14.3 85.3 9.1 90.6
[1.0-24.0] [81.4-88.9] [0.4-14.1] [88.2-94.4] [0.0-82.9] [82.1-89.2] [0.0-8.6] [98.0-100] [2.7-25.9] [81.5-89.1] [1.5-16.7] [87.4-93.8]
Icterus 12.1 93.0 14.3 91.7 40.0 93.0 7.1 99.1 13.9 93.2 17.9 91.1
[1.0-23.3] [90.3-95.7] [1.3-27.2] [88.8 -94.6] [0.0-82.9] [90.4-95.6] [0.0-16.7] [98.2-100.0] [2.6-25.2] [90.6-95.9] [3.7-32.0] [88.1-94.1]
Liver disease other than cancer 18.2 95.1 26.1 92.7 60.0 94.6 13.0 94.9 22.2 95.6 34.8 92.1
[5.0-31.3] [92.8-97.3] [8.1-44.0] [89.6 -95.1] [17.1-100.0] [92.3-96.9] [0.0-26.8] [92.6-97.1] [8.6-35.8] [93.4-97.8] [15.3-54.2] [89.2-94.9]
Transfusion prior 1992 3.0 94.4 5.0 91.0 0.0 94.6 0.0 98.6 2.8 94.4 5.0 90.1
[0.0-8.9] [92.0-96.9] [0.0-14.6] [88.0-94.0] [92.3-96.9] [97.4-99.8] [0.0-8.1] [91.9-96.8] [4.6-14.6] [87.0-93.2]
Relatives with viral hepatitis 6.1 95.3 11.1 91.4 0.0 95.1 0.0 98.6 5.6 95.3 11.1 90.5
[0.0-14.2] [93.1-97.6] [0.0-25.6] [88.5 -94.3] [93.0-97.3] [97.4-99.8] [0.0-13.0] [93.0-97.5] [0.0-25.6] [87.5-93.5]
Grand prematurity or serious health problem at birth 0.0 96.2 0.0 90.9 0.0 96.5 0.0 98.6 0.0 96.2 0.0 97.6
[94.2-98.2] [88.0-93.9] [94.6-98.4] [97.4-99.8] [94.1-98.2] [95.9-99.2]
Birth or medical care in countries at risk 3.0 97.4 10 91.3 0.0 97.3 0.0 98.9 2.8 97.4 10 90.4
[0.0-8.9] [95.7-99.1] [0.0-28.6] [88.4-94.2] [95.7-99.0] [97.4-99.8] [0.0-8.1] [95.6-99.1] [0.0-28.6] [87.4-93.5]
Transplantation prior 1992 0.0 98.3 0.0 91.1 0.0 98.4 0.0 98.6 0.0 98.2 0.0 90.2
[96.9-99.6] [88.2-94.0] [97.1-99.7] [97.5-99.8] [96.8-99.6] [87.2-93.3]
Blood derived product prior 1988 3.0 98.8 20.0 91.4 20 98.9 20 98.9 2.9 98.8 2 90.5
[0.0-8.9] [97.7-100.0] [0.0-55.1] [88.5-94.2] [0.0-55.1] [97.9-100] [0.0-55.1] [97.9-100.0] [0.0-8.4] [97.7-100] [0.0-55.1] [87.6-93.5]
Hemodialysis 0.0 99.4 0.0 91.2 0.0 99.5 0.0 98.7 0.0 99.4 0.0 90.4
[98.6-100.0] [88.3 -94.1] [98.7-100.0] [97.5-99.8] [98.6-100.0] [87.4-93.4]
Intravenous drug 3.0 100.0 100.0 91.5 0.0 99.7 0.0 98.7 2.8 100.0 100.0 90.7
[0.0-8.9] [88.7 -94.3] [99.2-100.0] [97.5-99.8] [0.0-8.1] [87.7-93.6]
Human Immunodeficiency Virus + 0.0 99.7 0.0 91.2 0.0 99.7 0.0 98.7 0.0 99.7 0.0 90.4
[97.1-100.0] [88.3-94.1] [99.2-100.0] [97.5-99.8] [99.1-100.0] [87.4-93.4]
One or more risk factor 45.5 56.4 9.1 91.5 100.0 56.9 3.0 100.0 50.0 56.8 10.9 91.5
[28.5-62.4] [51.2-61.6] [4.7-13.5] [87.8-95.3] [51.8-61.9] [0.4-5.6] [33.7-66.3] [51.5-62.0] [6.2-15.7] [87.7-95.2]
  1. a sensibility; b sensitivity; c positive predictive value; d negative predictive value